Published in Lupus on January 01, 2005
Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.91
Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis. Lupus (2012) 1.42
Sulphamethoxazole-trimethoprim in the treatment of limited paranasal Wegener's granulomatosis. Rheumatology (Oxford) (2002) 1.41
Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) (2003) 1.38
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis (2003) 1.38
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. Lupus (2013) 1.36
Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) (2005) 1.35
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum (2010) 1.26
The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) (2000) 1.25
Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus. Lupus (2003) 1.21
The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus (2009) 1.17
Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis (2003) 1.14
The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus (2009) 1.14
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis (2006) 1.00
Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol (1993) 0.99
Intracerebral arterial stenosis with neurological events associated with antiphospholipid syndrome. Rheumatology (Oxford) (2005) 0.99
Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) (2003) 0.99
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97
Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) (2004) 0.96
Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis (2005) 0.94
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis (2003) 0.93
Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis (1992) 0.91
Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis (2005) 0.89
Mathematical analysis of antigen selection in somatically mutated immunoglobulin genes associated with autoimmunity. Lupus (2010) 0.89
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Ann Rheum Dis (2004) 0.88
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) (2002) 0.88
Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin Exp Rheumatol (1992) 0.87
Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study. Lupus (1991) 0.87
The spectrum of ASIA: 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants'. Lupus (2012) 0.86
Difficult asthma or Churg-Strauss syndrome? BMJ (1999) 0.86
Hughes syndrome (the antiphospholipid syndrome): 25 years old. Mod Rheumatol (2008) 0.85
Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. Ann Rheum Dis (2007) 0.85
The NIH pulse cyclophosphamide regime: the end of an era? Lupus (2004) 0.84
Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum (2004) 0.84
Neurological manifestations of anti-phospholipid (Hughes) syndrome. Clin Exp Rheumatol (2005) 0.84
Periorbital oedema in systemic lupus erythematosus. Lupus (2003) 0.84
Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis. Rheumatology (Oxford) (2008) 0.84
Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis. Lupus (2013) 0.84
Mycophenolate mofetil treatment in resistant myositis. Rheumatology (Oxford) (2006) 0.83
Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy. Rheumatology (Oxford) (2005) 0.83
Association of HLA-DM polymorphism with the production of antiphospholipid antibodies. Ann Rheum Dis (2004) 0.83
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome. J Clin Immunol (2003) 0.83
Vasculitis, antiphospholipid antibodies, and renal artery stenosis. Ann Rheum Dis (2005) 0.82
Renal artery stenosis: a new facet of the antiphospholipid (Hughes) syndrome. Lupus (2003) 0.82
Atherogenesis in rheumatology. Lupus (2006) 0.82
Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford) (2004) 0.82
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol (2012) 0.81
Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies. Clin Exp Rheumatol (2006) 0.81
Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance. Ann Rheum Dis (2005) 0.81
Theory, targets and therapy in systemic lupus erythematosus. Lupus (2005) 0.80
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis (2002) 0.79
Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity. Ann Rheum Dis (2003) 0.79
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford) (2004) 0.79
Hypertension as the presenting feature of the antiphospholipid syndrome. Lupus (2002) 0.79
Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease. Clin Rheumatol (2006) 0.79
Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil. Clin Exp Rheumatol (2005) 0.78
Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. Lupus (2003) 0.78
Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome. Rheumatology (Oxford) (2007) 0.78
Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus (2007) 0.78
Syndrome X and Hughes syndrome. Lupus (2002) 0.77
Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study. Ann Rheum Dis (2006) 0.77
Increased risk of vascular complications in Takayasu's arteritis patients with positive lupus anticoagulant. Scand J Rheumatol (2014) 0.77
Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosis. Ann Rheum Dis (2006) 0.77
A case of mistaken identity: subacute bacterial endocarditis associated with p-antineutrophil cytoplasmic antibody. BMJ Case Rep (2010) 0.77
Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies. Ann Rheum Dis (2005) 0.77
Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome. Lupus (2008) 0.77
The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: a controlled study. Ann Rheum Dis (2008) 0.76
Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients. Ann Rheum Dis (2007) 0.76
Human Ro60 (SSA2) genomic organization and sequence alterations, examined in cutaneous lupus erythematosus. Br J Dermatol (2002) 0.76
Heparin and osteoporosis during pregnancy: 2002 update. Lupus (2002) 0.76
Pyridoxine toxicity courtesy of your local health food store. Ann Rheum Dis (2006) 0.76
Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis. Ann Rheum Dis (2008) 0.76
Migraine and antiphospholipid antibodies: no association found in migraine-discordant monozygotic twins. Cephalalgia (2008) 0.76
Antiendothelial cell antibodies (AECA) in patients with uveoretinitis. Clin Rev Allergy Immunol (1997) 0.76
Perspectives on the changing face of lupus mortality. Autoimmun Rev (2004) 0.76
Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. Arthritis Rheum (2002) 0.75